Vandetanib

• Description :

  Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  475.31

• Molecular Formula :

  C22H24BrFN4O2

• Notes :

  Research use only, not for human use.

• Receptor :

  EGFR| VEGFR2| VEGFR3

• CAS Number :

  443913-73-3